Effect of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Status:
Terminated
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to investigate if roflumilast can reduce the neutrophilic
inflammation at acute exacerbations of Chronic Obstructive Pulmonary Disease (COPD). In
addition, the potential benefit of roflumilast on severity and recovery periods of acute COPD
exacerbations will be assessed using patient diaries and questionnaires.